CONMED Corp (NASDAQ:CNMD)
| CAPS Rating |
|
|---|---|
| Open | $29.18 |
| Previous Close | $29.39 |
| Daily Range | $28.76 - $29.23 |
| 52-Week Range | $20.51 - $30.71 |
| Market Cap | $822.80M |
| P/E Ratio | 20.80 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 170,341 |
| Average Daily Volume | 0 |
CNMD
VS S&P 500 (SPY)
How do you think CNMD will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
CNMD Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
CNMD News and Commentary
- Are These Medical Companies Cash Kings? – The Motley Fool
- Hanger Outperforms in 4Q - Analyst Blog – NASDAQ
- Are CONMED's Numbers Better Than They Look? – The Motley Fool
- CONMED Passes This Key Test – The Motley Fool
- See the Future for Covidien by Checking This – The Motley Fool
- Does ResMed Pass Buffett's Test? – The Motley Fool
- Reiterating Hanger at Neutral - Analyst Blog – NASDAQ
- Are ArthroCare's Numbers Better Than They Look? – The Motley Fool
- Is ZOLL Medical Going to Burn You? – The Motley Fool
- Should You Get Out of Covidien Before Next Quarter? – The Motley Fool
- Let's See If ZOLL Medical's Growth Is for Real – The Motley Fool
- Is Zoll Medical the Perfect Stock? – The Motley Fool
- A Hidden Reason the Future Looks Bright for ZOLL Medical – The Motley Fool
- ResMed's Management Is Creating Value – The Motley Fool
- Don't Get Too Worked Up Over ZOLL Medical's Earnings – The Motley Fool
- ZOLL Medical Shares Popped: What You Need to Know – The Motley Fool
- Don't Get Too Worked Up Over Covidien's Latest Numbers – The Motley Fool
- Does ResMed Pass Buffett's Test? – The Motley Fool
- CONMED Earnings Preview – The Motley Fool
- The Street Should Expect Big Things from Boston Scientific – The Motley Fool
RSS Headlines
Fool UK
